New Mechanical Probe Detects Stem Cell Aging Through Integrin Force Signals

Mesenchymal stem cells (MSCs) are central to regenerative medicine and cell therapy, but their therapeutic potency declines with age. Current methods for detecting MSC aging—flow cytometry, immunoblotting, β-galactosidase labeling, and gene profiling—are predominantly biochemical. This study asked whether mechanical signals, specifically integrin-mediated forces, could serve as a biophysical readout of MSC aging.

The team first performed transcriptomic analysis comparing young (passage 5) and aged (passage 15) human MSCs. This revealed significant downregulation of cell adhesion-related genes, particularly integrin β1, in aged cells. Motivated by this finding, they engineered a GFP-RGD mechano-probe: a fusion protein consisting of GFP (which unfolds at ~60 pN) flanked by an RGD fibronectin motif and an Avi-tag for biotinylation. The probe was immobilized on glass-bottom Petri dishes via NeutrAvidin-biotin chemistry. When cells adhere and pull on the RGD ligand, GFP unfolds and fluorescence is quenched, creating quantifiable dark regions—called fluorescence loss zones—at focal adhesion sites that correspond to integrin tension.

Key results showed that young MSCs (P5) generated robust fluorescence loss signals, while aged MSCs (P8, P15) produced progressively weaker signals, indicating reduced integrin pulling forces with aging. These findings were validated orthogonally: flow cytometry confirmed higher senescence-associated β-galactosidase activity in aged cells, and immunoblots showed lower integrin β1 protein expression. Critically, overexpression of integrin β1 via lentiviral transduction in aged MSCs rescued mechanical signaling and elevated phosphorylated ERK (p-ERK), implicating the integrin β1/ERK pathway in maintaining contractility. The probe also successfully identified aged MSCs within mixed populations of young and old cells, and detected aging in adipose-derived MSCs freshly isolated from old versus young C57BL/6 mice—demonstrating translational relevance beyond cultured cell lines.

The findings are significant because they establish integrin tension as a measurable biophysical marker of MSC aging, complementing established biochemical markers. The mechano-probe approach is non-destructive and imaging-based, potentially allowing rapid, real-time assessment of MSC quality before therapeutic use. The correlation between reduced integrin β1 expression, diminished mechanical force generation, and impaired ERK signaling also provides mechanistic insight into how aging compromises MSC function at the cytoskeletal level.

Caveats include reliance on in vitro passaging as the primary aging model, which may not fully replicate physiological aging. The probe detects forces above the GFP unfolding threshold (~60 pN) but does not provide continuous force resolution across a broader range. Further work is needed to establish quantitative thresholds for clinical use and to explore whether force restoration via integrin β1 overexpression translates into improved therapeutic outcomes in vivo.